"Global Executive Summary Aromatase Inhibitors Market: Size, Share, and Forecast CAGR Value The aromatase inhibitors are supportive and aim to reduce the severity of the symptoms. Data Bridge Market Research analyses that the aromatase inhibitors market will grow at a CAGR of 5.60% during the forecast period of 2022 to 2029 Aromatase Inhibitors Market business report provides data on...

Executive Summary Asia-Pacific Automated Cell Cultures Market : CAGR Value Asia-Pacific automated cell cultures market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.8% in the forecast period of 2022 to 2029 and is expected to reach EURO 5,624.00 million by 2029. This...

  The global CRISPR technology market is entering a high-growth phase, underpinned by gene-editing breakthroughs, precision medicine, and strong public–private investment. Valued at around USD 3.6 billion in 2025 and projected to reach nearly USD 8.0 billion by 2033, the market is expected to grow at a CAGR of about 10.8% over 2025–2033.​ Browse Detailed Summary of...

The global prostate health market, encompassing therapies, diagnostics, and preventive solutions for conditions such as benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer, is projected to grow at a CAGR of 9.1% during the forecast period, reaching USD 68.0 billion by 2030. Rising awareness of men’s health, increasing screening rates, and...

Precision Medicine Market Overview: Trends, Growth, and Future Outlook The global precision medicine market is rapidly gaining momentum, fueled by groundbreaking advancements in genomics, biotechnology, and data-driven healthcare innovations. Valued at approximately USD 74.6 billion in 2025, this market is projected to soar to about USD 225.3 billion by 2033, expanding...

Market Overview The global oncology-based molecular diagnostics market is witnessing steady and sustained growth, reflecting the growing role of molecular-level technologies in transforming cancer care. Valued at USD 3.66 billion in 2024, the market is projected to reach USD 6.12 billion by 2034, expanding at a CAGR of 5.3% from 2025 to 2034. This growth...

The global peptide-based cancer therapeutics market is undergoing a period of rapid advancement, driven by the urgent need for effective, targeted cancer treatments and innovations in peptide drug design and delivery. According to recent industry analysis, the market was valued at USD 8.58 billion in 2019 and is projected to grow at a CAGR of 9.1%,...

The global nuclear medicine market size was valued at USD 6.19 billion in 2020 and is anticipated to grow at a CAGR of 9.0% during the forecast period, driven by rising cancer incidence, aging populations, and expanding diagnostic and therapeutic applications of radiopharmaceuticals. Unlike conventional imaging modalities, nuclear medicine offers functional and molecular-level insights,...

As precision oncology continues to evolve, HER2 (human epidermal growth factor receptor 2) has become one of the most established and clinically valuable therapeutic targets across a wide range of solid tumors. With growing insight into tumor heterogeneity and resistance mechanisms, the limitations of single-target, single-mechanism therapies are increasingly apparent. Improving efficacy while...